TITLE

Blocking leukotrienes optimize asthma control: The BLOC survey

AUTHOR(S)
Idrees, Majdy M.; Al Moamary, Mohamed S.
PUB. DATE
July 2007
SOURCE
Annals of Thoracic Medicine;Jul-Sep2007, Vol. 2 Issue 3, p99
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: The aim of this study was to evaluate asthma control after the introduction of a leukotriene modifier (Montelukast), in addition to the current controller asthma therapies, in patients with inadequately controlled mild-to-moderate persistent asthma. Asthma control and patient perception were assessed prior to, and 4 weeks after, the introduction of Montelukast, and the pre-introduction and post-introduction results were compared. Materials and Methods: A cross-sectional, observational study collected information on 1,490 eligible adult asthmatic patients in Saudi Arabia. The eligibility criteria included patients aged 15 years or more with symptomatic mild-to-moderate persistent asthma despite treatment with inhaled corticosteroids with or without long-acting beta agonist; also, the patient should attend the initial visit and follow-up visits after at least 4 weeks. Results: Of the 1,490 eligible patients, 79.5% received inhaled corticosteroids alone, and the remaining 20.5% received combination of inhaled corticosteroids and long-acting bronchodilator. Despite the treatment with daily controller medications, asthma symptoms persisted in more than two-thirds of the study population. Upon adding Montelukast, more than 80% of patients reported improvement in symptoms, which was consistent in all patients irrespective of corticosteroid type or dose (stratum) or the addition of long-acting β2-agonist. At the follow-up visit, 92.2% of patients reported that they felt better on Montelukast. Conclusion: Leukotriene modifier Montelukast has significant additive benefits in the management of patients who suffer from mild-to-moderate asthma and who are inadequately controlled on inhaled corticosteroids therapy with or without long-acting bronchodilator.
ACCESSION #
26069322

 

Related Articles

  • Step-Down Therapy for Controlled Mild Persistent Asthma.  // Travel Medicine Advisor;Aug2007, Vol. 17 Issue 8, p16 

    The article discusses a study on the suggested treatment for persistent asthma. Low-dose inhaled corticosteroids (LDIC) is used as an initial maintenance therapy and is used as a step-down therapy in reducing the use of pharmacotherapy without increasing asthma symptomatology. It is recommended...

  • Medical Therapy for Asthma: Updates from the NAEPP Guidelines. ELWARD, KURTIS S.; POLLART, SUSAN M. // American Family Physician;11/15/2010, Vol. 82 Issue 10, p1242 

    Proper care of patients with asthma involves the triad of systematic chronic care plans, self-management support, and appropriate medical therapy. Controller medications (inhaled corticosteroids, long-acting beta2 agonists, and leukotriene receptor antagonists) are the foundation of care for...

  • Antileukotrienes as Adjunctive Therapy in Acute Asthma. Kuitert, Lieske M. E.; Watson, Danie // Drugs;2007, Vol. 67 Issue 12, p1665 

    The leukotriene receptor antagonists (LTRAs) are a comparatively new class of asthma drugs that exhibit both bronchodilator and anti-inflammatory properties. There is a substantial body of evidence for their benefit in the management of chronic asthma in both adults and children, and...

  • Timing is everything. Ellis, Clare // Nature Reviews Drug Discovery;May2004, Vol. 3 Issue 5, p387 

    Looks at the study conducted by Richard Bond, et al, published in the 2004 issue of the "Proceedings of the National Academy of Sciences," indicating that beta-blockers which are presently contraindicated for asthmatics, might actually be able to prevent serious attacks. Influence of the...

  • Categorizing Asthma Severity:An Overview of National Guidelines. Colice, Gene L. // Clinical Medicine & Research;Aug2004, Vol. 2 Issue 3, p155 

    Asthma is an inflammatory disease of the airways associated with intermittent episodes of bronchospasm. Corticosteroids are the most effective anti-inflammatory class of medication currently available for the treatment of asthma. However, as higher doses of inhaled corticosteroids are used the...

  • Warning on low quality asthma prescribing.  // Pulse;5/21/2005, Vol. 65 Issue 20, p17 

    Reports that general practitioners in Great Britain are relying too heavily on reliever medication for high-risk asthma patients and under-prescribing inhaled steroids. Research headed by Henry Chrystyn, professor of clinical pharmacology at the University of Bradford; Analysis of patients who...

  • Safety and Effectiveness of Long-Acting Inhaled β-Agonist Bronchodilators When Taken with Inhaled Corticosteroids. Ernst, Pierre; McIvor, Andrew; M. Ducharme, Francine; Boulet, Louis-Philippe; FitzGerald, Mark; R. Chapman, Kenneth; Bai, Tony // Annals of Internal Medicine;11/7/2006, Vol. 145 Issue 9, p692 

    Long-acting β-agonists are a pillar of therapy for many patients with asthma because they are the preferred add-on therapy to inhaled corticosteroids. However, a recent meta-analysis documented a substantial increase in severe exacerbations requiring hospital admission and life-threatening...

  • Inhaler switch warning. Praities, Nigel // Pulse;5/7/2008, Vol. 68 Issue 16, p13 

    The article reports on the study from the University of Aberdeen which assesses the effectiveness of combined inhalers for asthma in Great Britain. The study reveals that the combined inhalers improve compliance and reduce the use of other healthcare products. Researchers argue that primary care...

  • Once-daily oral controller therapy with low-dose theophylline or montelukast was not effective in poorly controlled asthma: COMMENTARY. Thien, Francis // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p8 

    The author reflects on a study, published in an issue of the "American Journal of Respiratory and Critical Care Medicine," which focuses on the effectiveness of adding once-daily oral controller therapy to low-dose theophylline or montelukast in patients with poorly controlled asthma while...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics